# Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon

> **NCT01845701** · PHASE3 · COMPLETED · sponsor: **University of Yaounde 1** · enrollment: 720 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate-Amodiaquine
- **DRUG:** Dihydroartemisinine-Piperaquine
- **DRUG:** Artemether-lumefantrine combination

## Key facts

- **NCT ID:** NCT01845701
- **Lead sponsor:** University of Yaounde 1
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-04
- **Final completion:** 2015-04
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845701, "Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01845701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*